CELC (STOCKS)
Celcuity Inc. Common Stock
$91.850000
+5.250000 (+6.06%)
Prev close: $86.600000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Brian F. Sullivan
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $4,482.11M
- Employees
- 87
- P/E (TTM)
- -22.22
- P/B (TTM)
- 83.17
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
7
Strong Buy
10
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-1.44 | $-1.19 | -0.2522 | -21.23% |
|
Mar 2026 (Q1)
|
$-0.97 | $-1.07 | +0.1038 | +9.67% |
|
Dec 2025 (Q4)
|
$-0.97 | $-1.06 | +0.0927 | +8.72% |
|
Sep 2025 (Q3)
|
$-0.92 | $-1.03 | +0.1089 | +10.58% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | -$6.32M |
| Operating Expenses | $186.57M |
| Research and Development | $145.83M |
| Operating Income/Loss | -$186.57M |
| Income/Loss From Continuing Operations After Tax | -$192.89M |
| Income/Loss From Continuing Operations Before Tax | -$192.89M |
| Net Income/Loss | -$192.89M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$192.89M |
| Net Income/Loss Available To Common Stockholders, Basic | -$192.89M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$3.91 |
| Diluted Earnings Per Share | -$3.91 |
| Basic Average Shares | 147,688,376 |
| Diluted Average Shares | 147,688,376 |
| Assets | $410.16M |
| Current Assets | $408.93M |
| Noncurrent Assets | $1.24M |
| Fixed Assets | $619.00K |
| Other Non-current Assets | $616.00K |
| Liabilities | $356.64M |
| Current Liabilities | $33.21M |
| Accounts Payable | $10.45M |
| Other Current Liabilities | $22.76M |
| Noncurrent Liabilities | $323.43M |
| Long-term Debt | $137.87M |
| Other Non-current Liabilities | $185.56M |
| Equity | $53.53M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $53.53M |
| Liabilities And Equity | $410.16M |
| Net Cash Flow From Operating Activities | -$172.49M |
| Net Cash Flow From Operating Activities, Continuing | -$172.49M |
| Net Cash Flow From Investing Activities | -$53.83M |
| Net Cash Flow From Investing Activities, Continuing | -$53.83M |
| Net Cash Flow From Financing Activities | $355.03M |
| Net Cash Flow From Financing Activities, Continuing | $355.03M |
| Net Cash Flow | $128.71M |
| Net Cash Flow, Continuing | $128.71M |
| Comprehensive Income/Loss | -$192.89M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$192.89M |
| Other Comprehensive Income/Loss | $0.00 |